BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 36769158)

  • 1. Insights into the Peritumoural Brain Zone of Glioblastoma:
    Giambra M; Di Cristofori A; Conconi D; Marzorati M; Redaelli S; Zambuto M; Rocca A; Roumy L; Carrabba G; Lavitrano M; Roversi G; Giussani C; Bentivegna A
    Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterizing the peritumoral brain zone in glioblastoma: a multidisciplinary analysis.
    Lemée JM; Clavreul A; Aubry M; Com E; de Tayrac M; Eliat PA; Henry C; Rousseau A; Mosser J; Menei P
    J Neurooncol; 2015 Mar; 122(1):53-61. PubMed ID: 25559687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential gene expression in peritumoral brain zone of glioblastoma: role of SERPINA3 in promoting invasion, stemness and radioresistance of glioma cells and association with poor patient prognosis and recurrence.
    Nimbalkar VP; Kruthika BS; Sravya P; Rao S; Sugur HS; Verma BK; Chickabasaviah YT; Arivazhagan A; Kondaiah P; Santosh V
    J Neurooncol; 2021 Mar; 152(1):55-65. PubMed ID: 33389566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CDK4, CDK6, cyclin D1, p16(INK4a) and EGFR expression in glioblastoma with a primitive neuronal component.
    Xu G; Li JY
    J Neurooncol; 2018 Feb; 136(3):445-452. PubMed ID: 29150788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A highly potent CDK4/6 inhibitor was rationally designed to overcome blood brain barrier in gliobastoma therapy.
    Yin L; Li H; Liu W; Yao Z; Cheng Z; Zhang H; Zou H
    Eur J Med Chem; 2018 Jan; 144():1-28. PubMed ID: 29247857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined c-Met/Trk Inhibition Overcomes Resistance to CDK4/6 Inhibitors in Glioblastoma.
    Olmez I; Zhang Y; Manigat L; Benamar M; Brenneman B; Nakano I; Godlewski J; Bronisz A; Lee J; Abbas T; Abounader R; Purow B
    Cancer Res; 2018 Aug; 78(15):4360-4369. PubMed ID: 29844123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histopathological vascular investigation of the peritumoral brain zone of glioblastomas.
    Tamura R; Ohara K; Sasaki H; Morimoto Y; Yoshida K; Toda M
    J Neurooncol; 2018 Jan; 136(2):233-241. PubMed ID: 29188530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design of a brain-penetrant CDK4/6 inhibitor for glioblastoma.
    Bronner SM; Merrick KA; Murray J; Salphati L; Moffat JG; Pang J; Sneeringer CJ; Dompe N; Cyr P; Purkey H; Boenig GL; Li J; Kolesnikov A; Larouche-Gauthier R; Lai KW; Shen X; Aubert-Nicol S; Chen YC; Cheong J; Crawford JJ; Hafner M; Haghshenas P; Jakalian A; Leclerc JP; Lim NK; O'Brien T; Plise EG; Shalan H; Sturino C; Wai J; Xiao Y; Yin J; Zhao L; Gould S; Olivero A; Heffron TP
    Bioorg Med Chem Lett; 2019 Aug; 29(16):2294-2301. PubMed ID: 31307887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amplification of the cyclin-dependent kinase 4 (CDK4) gene is associated with high cdk4 protein levels in glioblastoma multiforme.
    Rollbrocker B; Waha A; Louis DN; Wiestler OD; von Deimling A
    Acta Neuropathol; 1996 Jul; 92(1):70-4. PubMed ID: 8811128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intratumoral heterogeneity in glioblastoma: don't forget the peritumoral brain zone.
    Lemée JM; Clavreul A; Menei P
    Neuro Oncol; 2015 Oct; 17(10):1322-32. PubMed ID: 26203067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p16-Cdk4-Rb axis controls sensitivity to a cyclin-dependent kinase inhibitor PD0332991 in glioblastoma xenograft cells.
    Cen L; Carlson BL; Schroeder MA; Ostrem JL; Kitange GJ; Mladek AC; Fink SR; Decker PA; Wu W; Kim JS; Waldman T; Jenkins RB; Sarkaria JN
    Neuro Oncol; 2012 Jul; 14(7):870-81. PubMed ID: 22711607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-124 radiosensitizes human glioma cells by targeting CDK4.
    Deng X; Ma L; Wu M; Zhang G; Jin C; Guo Y; Liu R
    J Neurooncol; 2013 Sep; 114(3):263-74. PubMed ID: 23761023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterizing the Genomic Profile in High-Grade Gliomas: From Tumor Core to Peritumoral Brain Zone, Passing through Glioma-Derived Tumorspheres.
    Giambra M; Messuti E; Di Cristofori A; Cavandoli C; Bruno R; Buonanno R; Marzorati M; Zambuto M; Rodriguez-Menendez V; Redaelli S; Giussani C; Bentivegna A
    Biology (Basel); 2021 Nov; 10(11):. PubMed ID: 34827152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain Exposure of Two Selective Dual CDK4 and CDK6 Inhibitors and the Antitumor Activity of CDK4 and CDK6 Inhibition in Combination with Temozolomide in an Intracranial Glioblastoma Xenograft.
    Raub TJ; Wishart GN; Kulanthaivel P; Staton BA; Ajamie RT; Sawada GA; Gelbert LM; Shannon HE; Sanchez-Martinez C; De Dios A
    Drug Metab Dispos; 2015 Sep; 43(9):1360-71. PubMed ID: 26149830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current Knowledge about the Peritumoral Microenvironment in Glioblastoma.
    Trevisi G; Mangiola A
    Cancers (Basel); 2023 Nov; 15(22):. PubMed ID: 38001721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-amplification of phosphoinositide 3-kinase enhancer A and cyclin-dependent kinase 4 triggers glioblastoma progression.
    Qi Q; Kang SS; Zhang S; Pham C; Fu H; Brat DJ; Ye K
    Oncogene; 2017 Aug; 36(32):4562-4572. PubMed ID: 28368413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression pattern and prognostic significance of myosin light chain 9 (MYL9): a novel biomarker in glioblastoma.
    Kruthika BS; Sugur H; Nandaki K; Arimappamagan A; Paturu K; Santosh V
    J Clin Pathol; 2019 Oct; 72(10):677-681. PubMed ID: 31270134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glypican 1 stimulates S phase entry and DNA replication in human glioma cells and normal astrocytes.
    Qiao D; Meyer K; Friedl A
    Mol Cell Biol; 2013 Nov; 33(22):4408-21. PubMed ID: 24019070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive analysis of the functional microRNA-mRNA regulatory network identifies miRNA signatures associated with glioma malignant progression.
    Li Y; Xu J; Chen H; Bai J; Li S; Zhao Z; Shao T; Jiang T; Ren H; Kang C; Li X
    Nucleic Acids Res; 2013 Dec; 41(22):e203. PubMed ID: 24194606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment and partial characterization of five malignant glioma cell lines.
    Zhang L; Yamane T; Satoh E; Amagasaki K; Kawataki T; Asahara T; Furuya K; Nukui H; Naganuma H
    Neuropathology; 2005 Jun; 25(2):136-43. PubMed ID: 15875906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.